Mersana Therapeutics, Inc. Long-Term Debt, Maturity, Year Five
Mersana Therapeutics, Inc. had Long-Term Debt, Maturity, Year Five of $10.42 million as of 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2022-02-28
- 2021-12-31: Long-Term Debt, Maturity, Year Five $10.42M.
- 2019-09-30: Long-Term Debt, Maturity, Year Five $334.00K.
- 2019-06-30: Long-Term Debt, Maturity, Year Five $334.00K.
| Period end | Long-Term Debt, Maturity, Year Five |
|---|---|
| 2021-12-31 | $10.42M 10-K · filed 2022-02-28 |
| 2019-09-30 | $334.00K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $334.00K 10-Q · filed 2019-08-08 |